• Home
  • About
  • TECHNOLOGY
  • INVESTORS
  • More
    • Home
    • About
    • TECHNOLOGY
    • INVESTORS
  • Home
  • About
  • TECHNOLOGY
  • INVESTORS

ECOGENOME Biotechnology Company

ECOGENOME Biotechnology CompanyECOGENOME Biotechnology CompanyECOGENOME Biotechnology Company

ECOGENOME Biotechnology Company

ECOGENOME Biotechnology CompanyECOGENOME Biotechnology CompanyECOGENOME Biotechnology Company

MISSION STATEMENT

PROVIDING MORE PRECISE CANCER THERAPY

  • Biotechnology Company
  • To provide informed cancer therapy choices by identifying individual tumor genetic vulnerabilities.  
  • Developing diagnostic tests for prostate cancer

EXECUTIVE SUMMARY

Genetic changes within a tumor may alter response to therapy. Testing of an individual patients tumor for therapeutic vulnerabilities may provide more precise therapy planning.

A DECADE OF PEER REVIEWED PROGRESS

The molecular genetic determinants of cancer therapy responses remains key to providing the right therapy at the right time.

A CULTURE OF SHARED PURPOSE

Our open, collaborative, culture provides support to enable cutting-edge work on molecular genetics for treatment-resistant cancers.

Contact Us

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ecogenome

3805 Old Easton Road, Doylestown, Pennsylvania 18902, United States

richard.pestell@ecogenomellc.com

Hours

Monday - Friday: 8:00am - 5:00pm

Saturday - Sunday: Closed

Copyright © 2023 Ecogenome - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept